BGI Genomics

BGI Genomics is one of the world’s largest DNA sequencing service providers.

BGI Genomics, founded in August, 2008 and headquartered in Shenzhen, is a genomics R&D institution. The founder is Wang Jian. Listed on the SZSE on July 14, 2017, the company's major shareholders are BGI Genomics Co.,Ltd., Shenzhen Qianhai BGI Investment Enterprise (LP) and Shenzhen Heyu Gaolin Equity Investment Partnership (LP). Rivals that have direct and indirect competition with BGI Genomics include Kintor, HitGen, Aprea Therapeutics, BridgeBio Pharma, etc.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Biotech

Founded

Jan 1, 1999

HQ location

Guangdong, China

Legal name

Shenzhen Huada Gene Technology Co., Ltd.

Employees

3585

See more